These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 10891549)

  • 41. Lactacystin enhances cisplatin sensitivity in resistant human ovarian cancer cell lines via inhibition of DNA repair and ERCC-1 expression.
    Li QQ; Yunmbam MK; Zhong X; Yu JJ; Mimnaugh EG; Neckers L; Reed E
    Cell Mol Biol (Noisy-le-grand); 2001; 47 Online Pub():OL61-72. PubMed ID: 11936875
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic values of excision repair cross-complementing genes mRNA expression in ovarian cancer patients.
    Zhao M; Li S; Zhou L; Shen Q; Zhu H; Zhu X
    Life Sci; 2018 Feb; 194():34-39. PubMed ID: 29247747
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Defects in interstrand cross-link uncoupling do not account for the extreme sensitivity of ERCC1 and XPF cells to cisplatin.
    De Silva IU; McHugh PJ; Clingen PH; Hartley JA
    Nucleic Acids Res; 2002 Sep; 30(17):3848-56. PubMed ID: 12202770
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nucleotide excision repair protein levels vis-à-vis anticancer drug resistance in 60 human tumor cell lines.
    Chen ZP; Malapetsa A; Monks A; Myers TG; Mohr G; Sausville EA; Scudiero DA; Panasci LC
    Ai Zheng; 2002 Mar; 21(3):233-9. PubMed ID: 12451985
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Strong functional interactions of TFIIH with XPC and XPG in human DNA nucleotide excision repair, without a preassembled repairosome.
    Araújo SJ; Nigg EA; Wood RD
    Mol Cell Biol; 2001 Apr; 21(7):2281-91. PubMed ID: 11259578
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cell cycle checkpoint abrogator UCN-01 inhibits DNA repair: association with attenuation of the interaction of XPA and ERCC1 nucleotide excision repair proteins.
    Jiang H; Yang LY
    Cancer Res; 1999 Sep; 59(18):4529-34. PubMed ID: 10493501
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mapping of interaction domains between human repair proteins ERCC1 and XPF.
    de Laat WL; Sijbers AM; Odijk H; Jaspers NG; Hoeijmakers JH
    Nucleic Acids Res; 1998 Sep; 26(18):4146-52. PubMed ID: 9722633
    [TBL] [Abstract][Full Text] [Related]  

  • 48. ERCC5/XPG, ERCC1, and BRCA1 gene status and clinical benefit of trabectedin in patients with soft tissue sarcoma.
    Italiano A; Laurand A; Laroche A; Casali P; Sanfilippo R; Le Cesne A; Judson I; Blay JY; Ray-Coquard I; Bui B; Coindre JM; Nieto A; Tercero JC; Jimeno J; Robert J; Pourquier P
    Cancer; 2011 Aug; 117(15):3445-56. PubMed ID: 21287534
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Effect of XPG down-regulation gene expression towards the proliferation of epithelial ovarian cancer cells and its chemosensitivity to platinum].
    Zhang W; Wu FX; Wang Q; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):286-91. PubMed ID: 22781116
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differences in nucleotide excision repair capacity between newly diagnosed colorectal cancer patients and healthy controls.
    Slyskova J; Naccarati A; Pardini B; Polakova V; Vodickova L; Smerhovsky Z; Levy M; Lipska L; Liska V; Vodicka P
    Mutagenesis; 2012 Mar; 27(2):225-32. PubMed ID: 22294771
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular Characteristics of ERCC1-Negative versus ERCC1-Positive Tumors in Resected NSCLC.
    Friboulet L; Barrios-Gonzales D; Commo F; Olaussen KA; Vagner S; Adam J; Goubar A; Dorvault N; Lazar V; Job B; Besse B; Validire P; Girard P; Lacroix L; Hasmats J; Dufour F; André F; Soria JC
    Clin Cancer Res; 2011 Sep; 17(17):5562-72. PubMed ID: 21750204
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Correction of liver dysfunction in DNA repair-deficient mice with an ERCC1 transgene.
    Selfridge J; Hsia KT; Redhead NJ; Melton DW
    Nucleic Acids Res; 2001 Nov; 29(22):4541-50. PubMed ID: 11713303
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The ERCC1 and ERCC4 (XPF) genes and gene products.
    Manandhar M; Boulware KS; Wood RD
    Gene; 2015 Sep; 569(2):153-61. PubMed ID: 26074087
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combining Phenotypes of Nucleotide Excision Repair Pathway to Predict the Risk of Head and Neck Squamous Cell Carcinomas in a Chinese Population.
    Liang Y; Zhang L; Chen Z; Chen J; Fang S; Zhang T; Zhu Y; Liu J; Li B; Shao Y; Xing J; Zhang S; Han P
    Dis Markers; 2022; 2022():4959737. PubMed ID: 36118674
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Influence of XPC, XPD, XPF, and XPG gene polymorphisms on the risk and the outcome of acute myeloid leukemia in a Romanian population.
    Bănescu C; Iancu M; Trifa AP; Dobreanu M; Moldovan VG; Duicu C; Tripon F; Crauciuc A; Skypnyk C; Bogliș A; Lazar E
    Tumour Biol; 2016 Jul; 37(7):9357-66. PubMed ID: 26779634
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Involvement of ERCC1/XPF and XPG in oligodeoxynucleotide-directed gene modification.
    Igoucheva O; Alexeev V; Scharer O; Yoon K
    Oligonucleotides; 2006; 16(1):94-104. PubMed ID: 16584298
    [TBL] [Abstract][Full Text] [Related]  

  • 57. ERCC1: a comparative genomic perspective.
    Wilson MD; Ruttan CC; Koop BF; Glickman BW
    Environ Mol Mutagen; 2001; 38(2-3):209-15. PubMed ID: 11746756
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Domains in the XPA protein important in its role as a processivity factor.
    Bartels CL; Lambert MW
    Biochem Biophys Res Commun; 2007 Apr; 356(1):219-25. PubMed ID: 17349973
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Computational Characterization of Small Molecules Binding to the Human XPF Active Site and Virtual Screening to Identify Potential New DNA Repair Inhibitors Targeting the ERCC1-XPF Endonuclease.
    Gentile F; Barakat KH; Tuszynski JA
    Int J Mol Sci; 2018 Apr; 19(5):. PubMed ID: 29710850
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans.
    Shen MR; Jones IM; Mohrenweiser H
    Cancer Res; 1998 Feb; 58(4):604-8. PubMed ID: 9485007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.